Facilities for the Future

Liquids & Semisolids

What Makes a Great Liquid Oral Dose CDMO?

Rob Terry

TriRx Pharmaceutical Services

Pathfinder

Offshoring vs. Reshoring vs. Half-Shoring: Which Manufacturing Strategy Is Best for Pharma?

Pharma's Almanac

Tech Transfer

Why Successful Scale-Up and Transfer Capabilities Increasingly Determine Outsourcing Success

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

Organoids

Building Bioreactors for Living Architecture: The Manufacturing Challenge for Clinical-Grade Organoids

David Alvaro, Ph.D.

Pharma's Almanac

Cell-Free Synthesis

Cell-Free Biomanufacturing and the Future of Flexible Biologics Production

David Alvaro, Ph.D.

Pharma's Almanac

Peptides

Enabling the Commercialization of Peptide Therapeutics with Manufacturing Advances

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

AI Data Integrity

Data Integrity in the Age of AI-Assisted Manufacturing

Pharma's Almanac

Continuous VV

The Stepwise Future of Continuous Viral Vector Manufacturing

David Alvaro, Ph.D.

Pharma's Almanac

Self-Healing

Beyond Cleaning: Could Self-Healing Materials Redefine Bioprocess Surfaces?

David Alvaro, Ph.D.

Pharma's Almanac

Psychedelics CMC

The CMC Challenge for Psychedelic Drugs

David Alvaro, Ph.D.

Pharma's Almanac